Search Results 1581-1590 of 16374 for Maximum

  1. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

    A lower stable MTX dose of 7.5-15 mg weekly will be allowed instead of at least 15 mg weekly if the maximum tolerated dose is in this range and a higher ...

  2. Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics - Mayo Clinic

    The purpose of this study is to establish the Maximum Tolerated Dose (MTD), assess the safety, tolerability, and pharmacokinetics of subcutaneous PHIN-214 ...

  3. Sleep tips: 6 steps to better sleep - Mayo Clinic

    Doing calming activities before bedtime, such as taking a bath or using relaxation techniques, might promote better sleep. 4. Limit daytime naps. Long ...

  4. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

    Concomitant high dose corticosteroids (concurrent use of corticosteroids); EXCEPTION: patients may be on chronic steroids (maximum dose 20 mg/day prednisone ...

  5. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Concurrent use of corticosteroids, but patients may be on chronic steroids (maximum dose 20 mg/day prednisone equivalent) if they are being given for disorders ...

  6. FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy - Mayo Clinic

    Patient must NOT weigh more than the maximum weight limit for the table for the PET/CT scanner at the institution where the study is being performed. The ...

  7. Type 1 diabetes - Diagnosis and treatment - Mayo Clinic

    Diagnosis. Diagnostic tests include: Glycated hemoglobin (A1C) test. This blood test shows your average blood sugar level for the past 2 to 3 months.

  8. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    A maximum of approximately 50% of subjects with any prior anti-TNF agent use will be allowed in the study. At the end of the double blind period, ... A ...

  9. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

    The objective of this study is to determine the safety, pharmacokinetics, maximum tolerated dose/recommended Phase 2 dose, and efficacy of PLX7486.

  10. Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients with Early Stage Non-Small Lung Cancer (NSCLC) - Mayo Clinic

    Patient must have a mass ≤ 5 cm maximum diameter by CT size estimate that is clinical stage I (T1N0, T2N0); Patient must have a CT scan of the chest and ...